Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Nocturnal lagophthalmos is the inability to close the eyelids while sleeping. This can result in a range of conditions from mild epithelial changes to severe exposure ulcers (Katz and Kaufman, 1977). Lagophthalmos is associated with exposure keratopathy, poor sleep, and…

Dr. Reginald J. Sanders, a distinguished physician affiliated with the Retina Group of Washington (RGW) and PRISM Vision Group, has been named as the new president of the American Society of Retina Specialists (ASRS). Dr. Sanders holds the distinction of…

In the realm of refractive surgery, individuals seeking visual freedom are presented with a plethora of options. Two prominent procedures, SMILE (Small Incision Lenticule Extraction) and LASIK (Laser-Assisted In Situ Keratomileusis), have emerged as front-runners, each with its unique benefits…

Formosa Pharmaceuticals announced a strategic licensing agreement with Cristália Produtos Químicos Farmacêuticos to secure exclusive commercialization rights for APP13007 (clobetasol propionate ophthalmic nanosuspension, 0.05%) in Brazil. APP13007 is designed for the treatment of inflammation and pain following ocular surgery and…

Allotex and SpA have announced the successful completion of the first close of their $30 million Series B financing. The funds raised will be utilized to further develop their technology aimed at treating refractive errors. The decision to invest in…

Ophthalmology Breaking News (OBN) is thrilled to present the first-ever interview with Dr. Filomena Ribeiro as the newly appointed President of the European Society of Cataract and Refractive Surgeons (ESCRS), effective January 1, 2024, succeeding Prof. Oliver Findl. Delve into…

In a recent announcement, Ocuphire Pharma disclosed that it has secured approval from the U.S. Food and Drug Administration (FDA) under a special protocol assessment (SPA) for the clinical trial protocol and planned statistical analysis of its LYNX-2 phase 3…

In a groundbreaking study published in The American Journal of Pathology, researchers at Mass Eye and Ear of the Harvard Medical School Department of Ophthalmology have unveiled a novel therapeutic approach using the neuropeptide α-melanocyte–stimulating hormone (α-MSH) to promote corneal…

Experiencing eye irritation after cataract surgery is not uncommon. While cataract surgery is generally safe and effective, it’s normal to experience some degree of discomfort in the postoperative phase. There can be several causes of eye irritation following the procedure.…

Becoming a skilled ophthalmologist requires a deep understanding of the complex field of eye care. While hands-on experience and clinical training are crucial, the knowledge gained from well-curated books can greatly enhance an ophthalmology resident’s expertise. In this article, we…